Blood counts did not demonstrate any significant difference between both AML subgroups in terms of WBC, Hb and platelet levels, bone marrow and peripheral blasts and especially with respect to absolute neutrophil counts (ANC) at AML primary diagnosis. The gene discussed is GSTM1; the disease is acute myeloid leukemia.